Stoke Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted from 2021 to 2023

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Stoke Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2021 to 2023.
  • Stoke Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 56.3M shares, a 27.3% increase year-over-year.
  • Stoke Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 44M shares, a 13.1% increase from 2022.
  • Stoke Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 38.9M shares, a 5.87% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.